Dasatinib Accordpharma 欧盟 - 斯洛文尼亚文 - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Acetilsalicilna kislina/psevdoefedrin 1A Pharma 500 mg/30 mg zrnca za peroralno 斯洛文尼亚 - 斯洛文尼亚文 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

acetilsalicilna kislina/psevdoefedrin 1a pharma 500 mg/30 mg zrnca za peroralno

1a pharma gmbh - acetilsalicilna kislina; psevdoefedrinijev klorid - zrnca za peroralno suspenzijo - acetilsalicilna kislina 500 mg / 1 vrečica  psevdoefedrinijev klorid30 mg / 1 vrečica; psevdoefedrinijev klorid 30 mg / 1 vrečica - acetilsalicilna kislina, kombinacije brez psiholeptikov

Acetilsalicilna kislina/psevdoefedrin 1A Pharma 500 mg/30 mg zrnca za peroralno 斯洛文尼亚 - 斯洛文尼亚文 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

acetilsalicilna kislina/psevdoefedrin 1a pharma 500 mg/30 mg zrnca za peroralno

1a pharma gmbh - acetilsalicilna kislina; psevdoefedrinijev klorid - zrnca za peroralno suspenzijo - acetilsalicilna kislina 500 mg / 1 vrečica  psevdoefedrinijev klorid30 mg / 1 vrečica; psevdoefedrinijev klorid 30 mg / 1 vrečica - acetilsalicilna kislina, kombinacije brez psiholeptikov